These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 7716704)

  • 41. Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus.
    Zhang F; Wu L; Qian J; Qu B; Xia S; La T; Wu Y; Ma J; Zeng J; Guo Q; Cui Y; Yang W; Huang J; Zhu W; Yao Y; Shen N; Tang Y
    J Autoimmun; 2016 Dec; 75():96-104. PubMed ID: 27481557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An Insight on the Pathogenesis and Treatment of Systemic Lupus Erythematosus.
    Ali M; Firoz CK; Jabir NR; Rehan M; Khan MS; Tabrez S
    Endocr Metab Immune Disord Drug Targets; 2018 Feb; 18(2):110-123. PubMed ID: 29219063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cytokines and lupus].
    Emilie D; Llorente L; Galanaud P
    Ann Med Interne (Paris); 1996; 147(7):480-4. PubMed ID: 9092358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular aspects in the pathogenesis of human systemic lupus erythematosus.
    Liossis SN; Tsokos GC
    Arch Immunol Ther Exp (Warsz); 2000; 48(1):11-9. PubMed ID: 10722226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IL-23: a promising therapeutic target for systemic lupus erythematosus.
    Leng RX; Pan HF; Chen GM; Wang C; Qin WZ; Chen LL; Tao JH; Ye DQ
    Arch Med Res; 2010 Apr; 41(3):221-5. PubMed ID: 20682181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expanding the B Cell-Centric View of Systemic Lupus Erythematosus.
    Morawski PA; Bolland S
    Trends Immunol; 2017 May; 38(5):373-382. PubMed ID: 28274696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic and immunological mechanisms in the pathogenesis of systemic lupus erythematosus.
    Drake CG; Kotzin BL
    Curr Opin Immunol; 1992 Dec; 4(6):733-40. PubMed ID: 1281640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytokines in systemic lupus erythematosus 2011.
    Poole BD; Niewold TB; Tsokos GC
    J Biomed Biotechnol; 2012; 2012():427824. PubMed ID: 22505810
    [No Abstract]   [Full Text] [Related]  

  • 49. [B-cell anomalies in systemic lupus erythematosus].
    Tron F; Jacquot S; Gilbert D
    Ann Med Interne (Paris); 2002 Dec; 153(8):503-12. PubMed ID: 12610424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Future therapy in systemic lupus erythematosus].
    Danielsen C; Alba P; Babini AM
    Rev Fac Cien Med Univ Nac Cordoba; 2011; 68(2):56-64. PubMed ID: 22440658
    [No Abstract]   [Full Text] [Related]  

  • 51. Interleukin-17-producing T cells in lupus.
    Crispín JC; Tsokos GC
    Curr Opin Rheumatol; 2010 Sep; 22(5):499-503. PubMed ID: 20592603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2015 Feb; 18(2):250-9. PubMed ID: 25639676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside.
    Yap DY; Lai KN
    Nephrology (Carlton); 2013 Apr; 18(4):243-55. PubMed ID: 23452295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intrinsic T cell defects in systemic autoimmunity.
    Kong PL; Odegard JM; Bouzahzah F; Choi JY; Eardley LD; Zielinski CE; Craft JE
    Ann N Y Acad Sci; 2003 Apr; 987():60-7. PubMed ID: 12727624
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abnormalities in the regulation of variable region genes that encode for antibodies to DNA may be a central factor in the pathogenesis of systemic lupus erythematosus.
    Singh AK
    Ann Rheum Dis; 1993 May; 52(5):378-83. PubMed ID: 8323386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic modalities in systemic lupus erythematosus.
    Tyagi NK; Lahita RG
    Saudi Med J; 2013 Sep; 34(9):887-95. PubMed ID: 24042998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The importance of HLA antigens for the prognosis of the course and effect of treatment in systemic lupus erythematosus].
    Benovolenskaia LI; Iakovleva DB; Folomeeva OM
    Vutr Boles; 1988; 27(6):48-52. PubMed ID: 3247704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of inflammatory markers associated with systemic lupus erythematosus patients undergoing treatment.
    Timóteo RP; Micheli DC; Teodoro RB; Freire M; Bertoncello D; Murta EF; Tavares-Murta BM
    Rev Bras Reumatol Engl Ed; 2016; 56(6):497-503. PubMed ID: 27914596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T helper cell subsets in the pathogenesis of systemic lupus erythematosus.
    Reininger L; Santiago ML; Takahashi S; Fossati L; Izui S
    Ann Med Interne (Paris); 1996; 147(7):467-71. PubMed ID: 9092356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic dissection of systemic lupus erythematosus.
    Wakeland EK; Wandstrat AE; Liu K; Morel L
    Curr Opin Immunol; 1999 Dec; 11(6):701-7. PubMed ID: 10631557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.